Contineum Therapeutics, Inc. (CTNM)

11.55 -0.03 (-0.26%) USD  |  NASDAQ  |  Dec 16, 16:00
11.77 +0.22 (+1.90%) After-Hours: 20:00
More

Contineum Therapeutics Enterprise Value: 121.90M for Dec. 16, 2025

Enterprise Value Chart

View Enterprise Value for CTNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Denali Therapeutics, Inc. 1.854B
Recursion Pharmaceuticals, Inc. 1.605B
CG Oncology, Inc. 2.213B
CEL-SCI Corp. 26.08M
AIM ImmunoTech, Inc. 0.9836M

Enterprise Value Related Metrics

Net Income (Quarterly) -12.79M
Total Expenses (Quarterly) 12.79M
EPS Diluted (Quarterly) -0.455
Earnings Yield -19.53%
Normalized Earnings Yield -19.53